Showing 1 - 6 results of 6 for search 'Anna Skowrońska', query time: 0.02s Refine Results
  1. 1
    PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK

    PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH... by Mariela Muraru, Anna Skowronska, Tyler Wilding, Sara Dyer, Nick Cross, Matthew Salmon, Laura Chiecchio, Andrew Beggs, Joanne Mason

    Published 2023-08-01
    Get full text
    Article
  2. 2
    PB2000: A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY

    PB2000: A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY by Joanne Mason, Anna Skowronska, Natalie Barrows, David Hill, Paula Page, Angela Hamblin, Sam Clokie, Andrew Feber, Robert Hastings, Nicholas Cross

    Published 2023-08-01
    Get full text
    Article
  3. 3
    ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

    ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele by Anna Skowronska, Belinda Austen, Judith E. Powell, Victoria Weston, David G. Oscier, Martin J.S. Dyer, Estella Matutes, Guy Pratt, Christopher Fegan, Paul Moss, Malcolm A. Taylor, Tatjana Stankovic

    Published 2012-01-01
    Get full text
    Article
  4. 4
    ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

    ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial by Matthew J.J. Rose-Zerilli, Jade Forster, Helen Parker, Anton Parker, Ana E. Rodríguez, Tracy Chaplin, Anne Gardiner, Andrew J. Steele, Andrew Collins, Bryan D. Young, Anna Skowronska, Daniel Catovsky, Tatjana Stankovic, David G. Oscier, Jonathan C. Strefford

    Published 2014-04-01
    Get full text
    Article
  5. 5
    Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants

    Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants by Angelo Agathanggelou, Victoria J. Weston, Tracey Perry, Nicholas J. Davies, Anna Skowronska, Daniel T. Payne, John S. Fossey, Ceri E. Oldreive, Wenbin Wei, Guy Pratt, Helen Parry, David Oscier, Steve J. Coles, Paul S. Hole, Richard L. Darley, Michael McMahon, John D. Hayes, Paul Moss, Grant S. Stewart, A. Malcolm R. Taylor, Tatjana Stankovic

    Published 2015-08-01
    Get full text
    Article
  6. 6
    Identification of novel 3D-genome altering and complex structural variants underlying retinitis pigmentosa type 17 through a multistep and high-throughput approach

    Identification of novel 3D-genome altering and complex structural variants underlying retinitis pigmentosa type 17 through a multistep and high-throughput approach by Suzanne E. de Bruijn, Daan M. Panneman, Nicole Weisschuh, Elizabeth L. Cadena, Erica G. M. Boonen, Lara K. Holtes, Galuh D. N. Astuti, Frans P. M. Cremers, Nico Leijsten, Jordi Corominas, Christian Gilissen, Anna Skowronska, Jessica Woodley, Andrew D. Beggs, Vasileios Toulis, Di Chen, Michael E. Cheetham, Alison J. Hardcastle, Terri L. McLaren, Terri L. McLaren, Tina M. Lamey, Jennifer A. Thompson, Fred K. Chen, Fred K. Chen, Fred K. Chen, John N. de Roach, John N. de Roach, Isabella R. Urwin, Lori S. Sullivan, Susanne Roosing

    Published 2024-10-01
    Get full text
    Article

Search Tools: